header-image

Navigating the Link Between Periodontitis and Systemic Disease



Navigating the Link Between Periodontitis and Systemic Disease

Zainab Malaki, BDS
Consultant in Periodontology, Guy’s and St Thomas Foundation Trust
Honorary Senior Clinical Lecturer, King’s College London

Periodontitis is a chronic, irreversible inflammatory disease initiated by bacterial biofilm and driven by a dysregulated host immune response, leading to destruction of the periodontal ligaments and alveolar bone and, if left untreated, ultimately tooth loss. Although plaque is the initiating factor, disease progression is strongly influenced by the host response, environmental exposures, and genetic susceptibility. Like other chronic non-communicable diseases, in most cases, symptoms associated with periodontitis do not develop until advanced stages, making it a “silent disease.” This could lead to late diagnosis of the disease.

Periodontitis is also highly prevalent, affecting over one billion people globally (GBD 2019), and shares key risk factors with systemic diseases such as cardiovascular disease (CVD) and diabetes mellitus (DM). These overlapping determinants highlight periodontitis as part of a broader systemic inflammatory burden rather than an isolated oral condition.

Periodontitis and Systemic Disease

Since the late 20th century, growing evidence has linked periodontitis with systemic conditions, including atherosclerotic cardiovascular disease (ACVD), diabetes, and adverse pregnancy outcomes. Most of these associations share inflammatory pathways, characterized by elevated systemic markers such as CRP, IL-6, and TNF-α, which provide biological plausibility.

However, causation remains unproven due to confounding factors and shared risk profiles. Age, smoking, obesity, and socioeconomic status influence both periodontal and systemic disease, making individual risk attribution complex.

Diabetes Mellitus: A Bidirectional Relationship

The strongest evidence exists for a bidirectional relationship between periodontitis and diabetes. Diabetes increases susceptibility to periodontal disease through impaired immune response, elevated salivary glucose, and delayed wound healing. Conversely, periodontitis contributes to poorer glycemic control via systemic inflammation.

Importantly, periodontal therapy has been associated with reductions in HbA1c of approximately 0.4%, an effect comparable to adding a second-line diabetic medication. This reinforces the clinical relevance of oral health in metabolic control and supports integration of dental care into diabetes pathways.

Despite this, many patients remain unaware of the association. Greater integration of screening, education, and referral pathways within diabetes services could improve outcomes and support earlier intervention.

Cardiovascular Disease

Emerging evidence also links periodontitis with CVD, including myocardial infarction, stroke, and peripheral artery disease. Patients with periodontitis demonstrate elevated inflammatory markers and endothelial dysfunction, both key contributors to atherosclerosis.

Recent interventional studies suggest that intensive periodontal therapy may improve vascular function and reduce inflammatory burden, independent of traditional cardiovascular risk factors. This supports the concept that periodontal inflammation may contribute to early vascular pathology and that periodontal care could help reduce cardiovascular risk.

Other Systemic Associations

Evidence also suggests associations between periodontitis and obesity, with a dose-dependent relationship between BMI (body mass index) and periodontal severity.

Mechanistically, obesity-related systemic inflammation may exacerbate periodontal destruction.

Hormonal fluctuations in women across puberty, pregnancy, and menopause also influence periodontal health, increasing susceptibility to gingival inflammation and disease progression (in the absence of effective oral hygiene). Pregnancy gingivitis is common, and while evidence linking periodontitis to adverse pregnancy outcomes remains inconclusive, periodontal treatment during pregnancy is considered safe and beneficial for maternal oral health.

Toward Integrated and Holistic Care

Despite increasing awareness, periodontal health remains underrepresented in medical guidelines and systemic disease management pathways. Opportunities exist for improved collaboration between dental and medical professionals, particularly in diabetes, cardiovascular, and antenatal care settings.

The future of periodontal care lies in a holistic, personalized “precision dentistry” approach that integrates risk assessment, prevention, and multidisciplinary collaboration. While microbiome-based diagnostics show promise, reliable predictive biomarkers for disease progression remain limited, reinforcing the multifactorial nature of periodontitis.

Conclusion

Periodontitis should no longer be viewed in isolation. It is a chronic inflammatory disease with meaningful systemic associations and potential bidirectional effects, particularly in diabetes and cardiovascular disease. Integrating periodontal care into broader healthcare pathways offers an opportunity to improve both oral and systemic health outcomes through a more connected, patient-centered approach.

Further reading:

  • GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 2020; 396(10258): 1204-22. doi:10.1016/S0140-6736(20)30925-9.
  •  https://www.efp.org/for-patients/gum-disease-general-health/perio-diabetes
  • Kim SH, Lee J, Kim WK, Lee YK, Kim YS. HbA1c changes in patients with diabetes following periodontal therapy. J Periodontal Implant Sci. 2021; 51(2): 114-123. doi:10.5051/jpis.2005620281. 
  • https://www.nice.org.uk/guidance/ng28 
  •  Orlandi M, Masi S, Lucenteforte E, Bhowruth D, Malanima M, Darbar U, Patel K, Lim C, Curra C, Shiehfung T, Suvan J, Chiesa S, Deanfield J, and D’Aiuto F. Periodontitis treatment and progression of carotid intima-media thickness: A randomized trial. European Heart Journal. 2025; 00: 1-12. doi:10.1093/eurheartj/ehaf555.
  • https://www.efp.org/publications-hub/how-periodontal-diseases-affect-womens-health-at-different-stages-of-life/
  • Cardoso IL, Fryde M, Guimarães MI, Leal F. Impact of female hormonal changes throughout life on oral health: A scoping review. Journal of Dental Sciences. 2026; 21: 31-48.